QQQ   267.51 (+0.39%)
AAPL   110.08 (+3.03%)
MSFT   202.54 (+1.07%)
FB   248.15 (-1.73%)
GOOGL   1,430.14 (-1.44%)
AMZN   2,960.47 (+0.19%)
NVDA   500.69 (+2.69%)
TSLA   449.39 (+1.64%)
BABA   273.82 (+0.52%)
CGC   15.74 (-3.79%)
GE   6.35 (-7.70%)
MU   49.15 (-3.13%)
AMD   77.94 (+4.02%)
T   28.63 (-1.04%)
F   6.87 (-4.98%)
ACB   6.32 (-3.22%)
GILD   64.21 (-1.29%)
NFLX   487.35 (+3.70%)
DIS   125.41 (-2.50%)
BAC   24.47 (-2.94%)
BA   156.35 (-2.97%)
QQQ   267.51 (+0.39%)
AAPL   110.08 (+3.03%)
MSFT   202.54 (+1.07%)
FB   248.15 (-1.73%)
GOOGL   1,430.14 (-1.44%)
AMZN   2,960.47 (+0.19%)
NVDA   500.69 (+2.69%)
TSLA   449.39 (+1.64%)
BABA   273.82 (+0.52%)
CGC   15.74 (-3.79%)
GE   6.35 (-7.70%)
MU   49.15 (-3.13%)
AMD   77.94 (+4.02%)
T   28.63 (-1.04%)
F   6.87 (-4.98%)
ACB   6.32 (-3.22%)
GILD   64.21 (-1.29%)
NFLX   487.35 (+3.70%)
DIS   125.41 (-2.50%)
BAC   24.47 (-2.94%)
BA   156.35 (-2.97%)
QQQ   267.51 (+0.39%)
AAPL   110.08 (+3.03%)
MSFT   202.54 (+1.07%)
FB   248.15 (-1.73%)
GOOGL   1,430.14 (-1.44%)
AMZN   2,960.47 (+0.19%)
NVDA   500.69 (+2.69%)
TSLA   449.39 (+1.64%)
BABA   273.82 (+0.52%)
CGC   15.74 (-3.79%)
GE   6.35 (-7.70%)
MU   49.15 (-3.13%)
AMD   77.94 (+4.02%)
T   28.63 (-1.04%)
F   6.87 (-4.98%)
ACB   6.32 (-3.22%)
GILD   64.21 (-1.29%)
NFLX   487.35 (+3.70%)
DIS   125.41 (-2.50%)
BAC   24.47 (-2.94%)
BA   156.35 (-2.97%)
QQQ   267.51 (+0.39%)
AAPL   110.08 (+3.03%)
MSFT   202.54 (+1.07%)
FB   248.15 (-1.73%)
GOOGL   1,430.14 (-1.44%)
AMZN   2,960.47 (+0.19%)
NVDA   500.69 (+2.69%)
TSLA   449.39 (+1.64%)
BABA   273.82 (+0.52%)
CGC   15.74 (-3.79%)
GE   6.35 (-7.70%)
MU   49.15 (-3.13%)
AMD   77.94 (+4.02%)
T   28.63 (-1.04%)
F   6.87 (-4.98%)
ACB   6.32 (-3.22%)
GILD   64.21 (-1.29%)
NFLX   487.35 (+3.70%)
DIS   125.41 (-2.50%)
BAC   24.47 (-2.94%)
BA   156.35 (-2.97%)
Log in
NASDAQ:CLLS

Cellectis News Headlines

$19.42
-1.42 (-6.81 %)
(As of 09/21/2020 12:00 AM ET)
Add
Compare
Today's Range
$19.29
Now: $19.42
$20.27
50-Day Range
$15.70
MA: $17.88
$20.84
52-Week Range
$7.32
Now: $19.42
$21.97
Volume98,806 shs
Average Volume167,792 shs
Market Capitalization$824.69 million
P/E RatioN/A
Dividend YieldN/A
Beta2.23

Headlines

Cellectis (NASDAQ CLLS) News Headlines Today

Source:
DateHeadline
Cellectis (NASDAQ:CLLS) Rating Increased to Hold at BidaskClubCellectis (NASDAQ:CLLS) Rating Increased to Hold at BidaskClub
marketbeat.com - September 18 at 4:21 AM
Cellectis (NASDAQ:CLLS) Upgraded by Citigroup to "Buy"Cellectis (NASDAQ:CLLS) Upgraded by Citigroup to "Buy"
marketbeat.com - August 19 at 7:44 AM
Analyzing Acceleron Pharma (NASDAQ:XLRN) and Cellectis (NASDAQ:CLLS)Analyzing Acceleron Pharma (NASDAQ:XLRN) and Cellectis (NASDAQ:CLLS)
americanbankingnews.com - September 20 at 1:51 PM
Cellectis (NASDAQ:CLLS) Shares Up 9.5%Cellectis (NASDAQ:CLLS) Shares Up 9.5%
americanbankingnews.com - September 14 at 7:26 PM
$2.63 Million in Sales Expected for Cellectis SA (NASDAQ:CLLS) This Quarter$2.63 Million in Sales Expected for Cellectis SA (NASDAQ:CLLS) This Quarter
americanbankingnews.com - September 9 at 2:54 AM
Monthly information on share capital and company voting rights - GlobeNewswireMonthly information on share capital and company voting rights - GlobeNewswire
globenewswire.com - September 7 at 6:21 PM
Cellectis to Participate in Upcoming Investor Conferences Paris Stock Exchange:ALCLS - GlobeNewswireCellectis to Participate in Upcoming Investor Conferences Paris Stock Exchange:ALCLS - GlobeNewswire
globenewswire.com - September 2 at 7:03 PM
Cellectis to Participate in Upcoming Investor ConferencesCellectis to Participate in Upcoming Investor Conferences
finance.yahoo.com - September 2 at 7:03 PM
Cellectis S.A. American Depositary Shares (CLLS)Cellectis S.A. American Depositary Shares (CLLS)
nasdaq.com - August 17 at 8:55 AM
Buy WiMi Hologram Cloud Stock to Play the Holographic AR Megatrend - NasdaqBuy WiMi Hologram Cloud Stock to Play the Holographic AR Megatrend - Nasdaq
nasdaq.com - August 7 at 1:23 PM
Blowout Earnings Should Add to the Rally in Activision Blizzard Stock - NasdaqBlowout Earnings Should Add to the Rally in Activision Blizzard Stock - Nasdaq
nasdaq.com - August 7 at 8:23 AM
Edited Transcript of ALCLS.PA earnings conference call or presentation 6-Aug-20 11:30am GMT - Yahoo FinanceEdited Transcript of ALCLS.PA earnings conference call or presentation 6-Aug-20 11:30am GMT - Yahoo Finance
finance.yahoo.com - August 7 at 8:23 AM
Century Aluminum (CENX) Q2 Earnings Miss, Sales Decline Y/Y - NasdaqCentury Aluminum (CENX) Q2 Earnings Miss, Sales Decline Y/Y - Nasdaq
nasdaq.com - August 7 at 12:55 AM
Energy Transfer (ET) Q2 Earnings Miss Estimates, Down Y/Y - NasdaqEnergy Transfer (ET) Q2 Earnings Miss Estimates, Down Y/Y - Nasdaq
nasdaq.com - August 7 at 12:55 AM
Higher Open Suggested For Indonesia Stock Market - NasdaqHigher Open Suggested For Indonesia Stock Market - Nasdaq
nasdaq.com - August 7 at 12:55 AM
ViacomCBS Rises 3.4% After Crushing Second-Quarter EPS Estimates - NasdaqViacomCBS Rises 3.4% After Crushing Second-Quarter EPS Estimates - Nasdaq
nasdaq.com - August 7 at 12:55 AM
Cellectis SA (CLLS) Q2 2020 Earnings Call Transcript - Motley FoolCellectis SA (CLLS) Q2 2020 Earnings Call Transcript - Motley Fool
fool.com - August 7 at 12:55 AM
Cellectis SA (CLLS) Q2 2020 Earnings Call TranscriptCellectis SA (CLLS) Q2 2020 Earnings Call Transcript
fool.com - August 6 at 10:13 PM
Allogene Therapeutics Reports Second Quarter 2020 Financial Results - StreetInsider.comAllogene Therapeutics Reports Second Quarter 2020 Financial Results - StreetInsider.com
streetinsider.com - August 6 at 7:50 PM
Cellectis S.A. (CLLS) CEO André Choulika on Q2 2020 Results - Earnings Call Transcript - Seeking AlphaCellectis S.A. (CLLS) CEO André Choulika on Q2 2020 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - August 6 at 7:50 PM
2020 Competitive Landscape Analysis of Recent Cell and Gene Therapy Innovations - ResearchAndMarkets.com - Benzinga2020 Competitive Landscape Analysis of Recent Cell and Gene Therapy Innovations - ResearchAndMarkets.com - Benzinga
benzinga.com - August 5 at 6:47 PM
Cellectis Provides Business Update and Reports Financial Results for Second Quarter and First Six Months 2020 - GlobeNewswireCellectis Provides Business Update and Reports Financial Results for Second Quarter and First Six Months 2020 - GlobeNewswire
globenewswire.com - August 5 at 6:47 PM
Form SC 13D Cellectis SA Filed by: Bpifrance Participations SA - StreetInsider.comForm SC 13D Cellectis SA Filed by: Bpifrance Participations SA - StreetInsider.com
streetinsider.com - August 4 at 5:45 PM
Cellectis to Hold Second Quarter 2020 Earnings Call on Thursday, August 6, 2020 at 7:30AM EDT - GlobeNewswireCellectis to Hold Second Quarter 2020 Earnings Call on Thursday, August 6, 2020 at 7:30AM EDT - GlobeNewswire
www.globenewswire.com - July 29 at 8:04 PM
Cellectis to Hold Second Quarter 2020 Earnings Call on Thursday, August 6, 2020 at 7:30AM EDTCellectis to Hold Second Quarter 2020 Earnings Call on Thursday, August 6, 2020 at 7:30AM EDT
finance.yahoo.com - July 29 at 8:04 PM
Global Cart Cell Therapy Market To Grow At A CAGR of 29.4% With The Emergence Of Immunotherapies In Medical Treatment - Yahoo FinanceGlobal Cart Cell Therapy Market To Grow At A CAGR of 29.4% With The Emergence Of Immunotherapies In Medical Treatment - Yahoo Finance
finance.yahoo.com - July 24 at 1:14 PM
Cellectis Appoints Biopharma Veteran Steve Doares, Ph.D., as Senior Vice President of US Manufacturing - Yahoo FinanceCellectis Appoints Biopharma Veteran Steve Doares, Ph.D., as Senior Vice President of US Manufacturing - Yahoo Finance
finance.yahoo.com - July 22 at 7:37 AM
Cellectis Appoints Biopharma Veteran Steve Doares, Ph.D., as Senior Vice President of US Manufacturing - GlobeNewswireCellectis Appoints Biopharma Veteran Steve Doares, Ph.D., as Senior Vice President of US Manufacturing - GlobeNewswire
www.globenewswire.com - July 21 at 5:55 PM
Cellectis Appoints Biopharma Veteran Steve Doares, Ph.D., as Senior Vice President of US ManufacturingCellectis Appoints Biopharma Veteran Steve Doares, Ph.D., as Senior Vice President of US Manufacturing
finance.yahoo.com - July 21 at 5:55 PM
The Daily Biotech Pulse: Novavax Lands $1.6B For COVID-19 Vaccine, Amgen Prevails In Avastin Biosimilar Lawsuit, Cellectis Study Placed On Clinical Hold - BenzingaThe Daily Biotech Pulse: Novavax Lands $1.6B For COVID-19 Vaccine, Amgen Prevails In Avastin Biosimilar Lawsuit, Cellectis Study Placed On Clinical Hold - Benzinga
www.benzinga.com - July 7 at 8:25 AM
Calyxt Announces Board Changes - Yahoo FinanceCalyxt Announces Board Changes - Yahoo Finance
finance.yahoo.com - July 7 at 8:25 AM
7 Stocks Moving In Mondays After-Hours Session - Benzinga7 Stocks Moving In Monday's After-Hours Session - Benzinga
www.benzinga.com - July 6 at 7:18 PM
BRIEF-Cellectis SA Says Melani-01 Trial Has Been Placed On Clinical Hold By U.S. FDA - ReutersBRIEF-Cellectis SA Says Melani-01 Trial Has Been Placed On Clinical Hold By U.S. FDA - Reuters
www.reuters.com - July 6 at 7:18 PM
Cellectis Reports Clinical Hold Placed on MELANI-01 Study - GlobeNewswireCellectis Reports Clinical Hold Placed on MELANI-01 Study - GlobeNewswire
www.globenewswire.com - July 6 at 7:18 PM
Cellectis Reports Clinical Hold Placed on MELANI-01 StudyCellectis Reports Clinical Hold Placed on MELANI-01 Study
finance.yahoo.com - July 6 at 7:18 PM
To Fully Focus on Cellectis, Dr. André Choulika Retires From Calyxt’s Board of DirectorsTo Fully Focus on Cellectis, Dr. André Choulika Retires From Calyxt’s Board of Directors
finance.yahoo.com - July 6 at 7:18 PM
Cellectis SA (CLLS): Hedge Funds Are Snapping Up - Yahoo FinanceCellectis SA (CLLS): Hedge Funds Are Snapping Up - Yahoo Finance
finance.yahoo.com - July 5 at 11:39 PM
Form 6-K Cellectis SA For: Jun 30 - StreetInsider.comForm 6-K Cellectis SA For: Jun 30 - StreetInsider.com
www.streetinsider.com - June 30 at 8:32 PM
Cellectis Starting To Look Like A Biotech Buy - Seeking AlphaCellectis Starting To Look Like A Biotech Buy - Seeking Alpha
seekingalpha.com - June 29 at 5:37 PM
Cellectis S.A. Reports Results from Annual Shareholders General Meeting Held on June 29, 2020 - GlobeNewswireCellectis S.A. Reports Results from Annual Shareholders' General Meeting Held on June 29, 2020 - GlobeNewswire
www.globenewswire.com - June 29 at 5:37 PM
Cellectis S.A. Reports Results from Annual Shareholders’ General Meeting Held on June 29, 2020Cellectis S.A. Reports Results from Annual Shareholders’ General Meeting Held on June 29, 2020
finance.yahoo.com - June 29 at 5:37 PM
Cellectis Published Streamlined Manufacturing Method to Generate Ultrapure Allogeneic CAR T-Cell Therapies - GlobeNewswireCellectis Published Streamlined Manufacturing Method to Generate Ultrapure Allogeneic CAR T-Cell Therapies - GlobeNewswire
www.globenewswire.com - June 26 at 3:10 PM
Cellectis Published Streamlined Manufacturing Method to Generate Ultrapure Allogeneic CAR T-Cell Therapies - Yahoo FinanceCellectis Published Streamlined Manufacturing Method to Generate Ultrapure Allogeneic CAR T-Cell Therapies - Yahoo Finance
finance.yahoo.com - June 25 at 6:17 PM
Cellectis Published Streamlined Manufacturing Method to Generate Ultrapure Allogeneic CAR T-Cell TherapiesCellectis Published Streamlined Manufacturing Method to Generate Ultrapure Allogeneic CAR T-Cell Therapies
finance.yahoo.com - June 25 at 6:17 PM
Insights on the CRISPR Global Industry to 2028 - Featuring Applied Stemcell, Caribou Biosciences & Cellectis Among Others - GlobeNewswireInsights on the CRISPR Global Industry to 2028 - Featuring Applied Stemcell, Caribou Biosciences & Cellectis Among Others - GlobeNewswire
www.globenewswire.com - June 25 at 8:01 AM
Allogene Therapeutics (ALLO) Highlights Findings Supporting an Allogeneic DLL3 CAR for SCLC & Development of Inducible TurboCAR - StreetInsider.comAllogene Therapeutics (ALLO) Highlights Findings Supporting an Allogeneic DLL3 CAR for SCLC & Development of Inducible TurboCAR - StreetInsider.com
www.streetinsider.com - June 23 at 11:26 PM
Allogene Therapeutics Announces Publication Highlighting Potential for ALLO-819 In Acute Myeloid Leukemia - StreetInsider.comAllogene Therapeutics Announces Publication Highlighting Potential for ALLO-819 In Acute Myeloid Leukemia - StreetInsider.com
www.streetinsider.com - June 23 at 12:45 AM
Allogene Therapeutics Presents Preclinical Findings Supporting an Allogeneic DLL3 CAR for Small Cell Lung Cancer and Development of an Inducible TurboCAR™ at the American Association for Cancer Research (AACR) Virtual 2020 Meeting - Yahoo FinanceAllogene Therapeutics Presents Preclinical Findings Supporting an Allogeneic DLL3 CAR for Small Cell Lung Cancer and Development of an Inducible TurboCAR™ at the American Association for Cancer Research (AACR) Virtual 2020 Meeting - Yahoo Finance
finance.yahoo.com - June 22 at 7:44 PM
Cellectis: An Expert Review on Allogeneic CAR-T for Cancer Published in Nature Reviews Drug DiscoveryCellectis: An Expert Review on Allogeneic CAR-T for Cancer Published in Nature Reviews Drug Discovery
www.bloomberg.com - June 20 at 5:44 PM
Epsilen Bio appoints Julia Berretta as Chief Executive Officer and Mathieu Simon as Chairman of the Board - Yahoo FinanceEpsilen Bio appoints Julia Berretta as Chief Executive Officer and Mathieu Simon as Chairman of the Board - Yahoo Finance
finance.yahoo.com - June 15 at 2:17 PM
Epsilen Bio appoints Julia Berretta as Chief Executive Officer and Mathieu Simon as Chairman of the Board - Business WireEpsilen Bio appoints Julia Berretta as Chief Executive Officer and Mathieu Simon as Chairman of the Board - Business Wire
www.businesswire.com - June 15 at 4:16 AM
Cellectis S.A. ADRCellectis S.A. ADR
www.barrons.com - June 12 at 10:32 PM
This page was last updated on 9/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.